ICA Group Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

ICA Group Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$61.7K	Sell	666 -15	-2%	-$1.34K	0.04%	219
2024 Q1	$64.6K	Buy	681 +381	+127%	+$35.4K	0.01%	492
2023 Q4	$26.8K	Buy	+300	New	+$22.3K	0.01%	650
2023 Q3	–	Sell	-9	Closed	-$749	–	1253
2023 Q2	$749	Buy	+9	New	+$753	﹤0.01%	1222

Other funds holding XBI

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

ICA Group Wealth Management's XBI Position: Q2 2024 in Review

ICA Group Wealth Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.2% in Q2 2024, selling an estimated $1.34K and leaving 666 shares worth $61.7K. The position accounts for 0.04% of the portfolio, ranked #219.

ICA Group Wealth Management first reported a position in XBI in Q2 2023 and has held it in 4 quarters since. The position peaked at $64.6K in Q1 2024. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

ICA Group Wealth Management held 666 shares of State Street SPDR S&P Biotech ETF worth $61.7K as of Q2 2024.
ICA Group Wealth Management sold 15 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $1.34K.
State Street SPDR S&P Biotech ETF made up 0.04% of ICA Group Wealth Management's portfolio in Q2 2024, its #219 holding.
ICA Group Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and has held it in 4 quarters since.
ICA Group Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $64.6K in Q1 2024.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.